1. The document lists 10 references in Vancouver style. The references are related to topics around prevention of conditions like diabetes, hepatitis, and cardiovascular disease. They cover studies on lifestyle interventions, risk factors, natural compounds, and statin use.

1. Citas bibliográficas en Vancouver.
PreventionAND(diabetesORhepatitis)
1. CarelsRA,SelenskyJC,Rossi J,SolarC,HlavkaR. A novel stepped-care approachto
weightloss:The role of self-monitoringand healthliteracyintreatmentoutcomes.Eat
Behav[Internet].2017;26:76–82. Available from:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85011919154&doi=10.1016%2Fj.eatbeh.2017.01.009&partnerID=40&md5=187e5c1e9
3427250054e6354cbcdd76e
2. González-ChicaDA,Dal Grande E, BowdenJ,MuskerM, Hay P,Stocks N.Are we
reducingthe riskof cardiovasculardisease andimprovingthe qualityof lifethrough
preventivehealthcare?Resultsof apopulation-basedstudyinSouthAustralia.Prev
Med (Baltim) [Internet].2017;99:164–70. Available from:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85014438451&doi=10.1016%2Fj.ypmed.2017.02.007&partnerID=40&md5=ad4fddc72c
35d764fbf127aa9230ae10
3. MezukB, Concha JB,PerrinP, GreenT. Commentary:Reconsideringthe role of context
indiabetesprevention.EthnDis[Internet].2017;27(1):63–8. Availablefrom:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85013409006&doi=10.18865%2Fed.27.1.63&partnerID=40&md5=50e916ed6e21ab408
f516e60965d5f9e
4. AguiarJ, CostaR, Rocha F, EstevinhoBN,SantosL.Designof microparticlescontaining
natural antioxidants:Preparation,characterizationandcontrolledreleasestudies.
PowderTechnol [Internet].2017;313:287–92. Availablefrom:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85015367919&doi=10.1016%2Fj.powtec.2017.03.013&partnerID=40&md5=9f7ec3ea73
2950c213c96d1a3afd5b08
5. Patel MH, Patel RD, VanikarA V,KanodiaK V,Suthar KS,NigamLK, etal. Invasive fungal
infectionsinrenal transplantpatients:asingle centerstudy.RenFail [Internet].
2017;39(1):294–8. Availablefrom:https://www.scopus.com/inward/record.uri?eid=2-
s2.0-
85015355227&doi=10.1080%2F0886022X.2016.1268537&partnerID=40&md5=b67b33f
0661bc5387e4a13b0d86f0178
6. Li H, Yan X, DengX, Yang L, Zhao S,Zou J, etal. Magnitude of andgenderdifferencesin
cardiovascularriskprofilesamongcommunityresidentsinShenzhen,China.Public
Health[Internet].2017;147:59–65. Available from:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85014938126&doi=10.1016%2Fj.puhe.2017.02.008&partnerID=40&md5=e44a5e3a311
a8298b6060c9ae9ea8133
7. Patel H, Royall PG,GaisfordS,WilliamsGR,EdwardsCH, Warren FJ,et al.Structural and
enzyme kineticstudiesof retrogradedstarch:Inhibitionof α-amylaseandconsequences
for intestinaldigestionof starch.CarbohydrPolym[Internet].2017;164:154–61.

2. Available from:https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85012283283&doi=10.1016%2Fj.carbpol.2017.01.040&partnerID=40&md5=0bb9e88bc
8e33cad693d1658eb4f9818
8. Gajęcka M, Przybylska-GornowiczB,Zakłos-SzydaM,Dąbrowski M, MichalczukL,
KoziołkiewiczM,etal. The influence of anatural triterpene preparationonthe
gastrointestinal tractof giltswithstreptozocin-induceddiabetesandoncell metabolic
activity. JFunct Foods[Internet].2017;33:11–20. Available from:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85015436270&doi=10.1016%2Fj.jff.2017.03.019&partnerID=40&md5=847c1f074f25e2
ca1de8507d2bb2bef6
9. AthyrosVG,AlexandridesTK,BilianouH,CholongitasE,DoumasM, GanotakisES,et al.
The use of statinsalone,orin combinationwithpioglitazone andotherdrugs,forthe
treatmentof non-alcoholicfattyliverdisease/non-alcoholicsteatohepatitisandrelated
cardiovascularrisk.AnExpertPanel Statement.Metabolism[Internet].2017;71:17–32.
Available from:https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85015044198&doi=10.1016%2Fj.metabol.2017.02.014&partnerID=40&md5=7f5033ca7
f479a1cf7b8e978c0e91b70
10. Li Y, BerensonJ,Moran AE, PagánJA.Who doesnot reduce theirsodiumintake despite
beingadvisedtodoso?A populationsegmentationanalysis.PrevMed(Baltim)
[Internet].2017;99:77–9. Availablefrom:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
85013632315&doi=10.1016%2Fj.ypmed.2017.01.017&partnerID=40&md5=fad4a771cc
713eddc3476d11fb3ec84e